mAbxience | News

mAbxience, European success accelerating global growth

02/13/2017

mAbxience is proud to announce that it has recently received the GMP Certification from the Spanish Agency of Medicines and Health Products (AEMPS), one of the strictest and highest regarded regulatory agencies in the world. This is another success towards realization of our international growth plan.  With this certification mAbxience now has the green light […]

mAbxience, present in the World Biosimilar Congress Europe 2016

11/23/2016

Last week mAbxience took part in one of the landmark events of the biosimilar sector, the World Biosimilar Congress Europe 2016, held on 14th and 15th November in Basel, Switzerland. As every year, the most important companies of the industry attended this event, as well as representatives of official organisms of the sector and universities. […]

mAbxience, winner of the Biosimilar Initiative of the Year Award 2016

10/06/2016

mAbxience received the Biosimilar Initiative of the Year  award at the “Global Generics & Biosimilars” ceremony held on 4th October by the prestigious British “Generics Bulletin” in Barcelona, which coincided with the industrial excellence fair, the CPhI Worldwide. This publication, which organises these awards each year to highlight the industry’s achievements over the previous year, selected […]

Another participation in the CPhI

09/29/2016

mAbxience will participate for a second consecutive year in the industrial excellence fair, the CPhI, which will celebrate its next event from 4 to 6 October in Barcelona. This is one of the most important events in the pharmaceutical industry, and is attended by more than 36,000 professionals from over 150 different countries to learn […]

Biosimilars in Europe – Protagonist of BioSpain 2016

09/29/2016

What are the short- and medium-term prospects and opportunities for biosimilars? A round table, organised by the biotechnology company mAbxience, which specialises in the development of biosimilars, will answer this and many more questions. The round table will take place within the framework of BioSpain 2016, a biotechnology reference summit that will be held from […]

mAbxience at the Congress of the Spanish Society for Microbiology

09/26/2016

The 6th Congress of Industrial Microbiology and Microbial Biotechnology, which was sponsored by the Spanish Society for Microbiology (SEM), was held at the University of León from 12 to 14 September. Different scientific sessions were held during the event, which is a perfect forum for discussion among researchers and students. mAbxience was present at this […]

6 out of 10 Doctors have already prescribed Biosimilar Medicines, according to EuropaBio Paper

09/09/2016

88,6% of doctors know what biosimilar medicines are and 59% have already prescribed biosimilar medicines as a high quality treatment for their patients, according to EuropaBio paper on physician preference regarding biosimilar labels. Source: Medicines for Europe 

mAbxience attends the Annual Congress of Biotecnology: a day with future biotechnologists

08/02/2016

On 13 July, the director of the mAbxience plant in León, Luisa Amoedo, led a Biomentoring session as part of the Annual Congress of Biotech¬nology (BAC), one of the sector’s biggest events in Spain, organised by the Spanish Federation of Biotechnologists (FEBiotec), held this year at the University of Gijón.   In her presentation, entitled […]

mAbxience attends the event ‘Science to Business: Successful case studies in the development of innovators and biosimilars’

05/27/2016

On 24 May, Azierta, a consultancy firm specialising in science and health, organised the ‘Science to Business: Successful case studies in the development of innovators and biosimilars’ event in Barcelona. The aim of this event was to look at different successful case studies in the development of innovative and biosimilar products in order to analyse […]

mAbxience has a commitment to local talent, with a workforce that is 80% Leonese

05/25/2016

The mayor of León, Antonio Silván, and the founder of mAbxience, Hugo Sigman, visited the biotech company’s facilities located in the León Technology Park. They were accompanied during the visit by Lucas Sigman, mAbxience Industrial Director and Luisa Amoedo, director of the mAbxience León Plant. From the city council, the mayor was accompanied by the […]